Surgery on Metastatic Foci is a Better Strategy for Stage IV Breast Cancer Patients with only Nonregional Lymph Node Metastasis.
Yile JiaoXinyi GuoHao WuQing LvPublished in: Advances in therapy (2023)
Surgery on NRLN and radiotherapy for the primary tumor improved the prognosis of NRLN metastatic patients. Thus, the classification of NRLN, especially contralateral axillary lymph node metastasis (CAM), into the M1 breast cancer stage should be reconsidered. Different locoregional treatment strategies for metastatic foci should be recommended for patients with only NRLN and patients with visceral metastasis.
Keyphrases
- lymph node metastasis
- squamous cell carcinoma
- papillary thyroid
- minimally invasive
- small cell lung cancer
- coronary artery bypass
- end stage renal disease
- locally advanced
- newly diagnosed
- chronic kidney disease
- machine learning
- early stage
- lymph node
- neoadjuvant chemotherapy
- surgical site infection
- prognostic factors
- deep learning
- sentinel lymph node
- peritoneal dialysis
- coronary artery disease
- skeletal muscle
- acute coronary syndrome